Skip to main content
. Author manuscript; available in PMC: 2009 Sep 1.
Published in final edited form as: Am J Gastroenterol. 2008 Aug 5;103(9):2263–2271. doi: 10.1111/j.1572-0241.2008.02034.x

Table 4.

Age-standardized mortality* by presence of NAFLD in three studies

NHANES III Population Based Cohort Olmsted County Case Series Cleveland Clinic Case Series
Reference (n=6594) Suspected NAFLD (n=980) Imaging (n=284) Biopsy (n=53) Biopsy (n=120)
All-cause Mortality 129 (118 – 140) 154 (116 – 198) 156 (102 – 221) 474 (284 – 705) 426 (298 – 573)
Cardiovascular Disease 44 (39 – 50) 43 (24 – 67) 56 (26 – 95) 19 (0 – 52) 87 (32 – 161)
Malignant Neoplasm 37 (32 – 43) 40 (23 – 61) 10 (2–22) 259 (122 – 438) 112 (50 – 195)
Liver Disease 1 (1 – 2) 5 (0 – 12) 26 (7 – 53) 35 (4 – 84) 62 (27 – 107)
*

directly standardized to the 2000 U.S. population, ages 35–84 years